Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Gene expression
Molecular diagnostic test study continues EET benefit assessment
By
Liz Carey
A molecular oncology gene expression profiling (GEP) test for breast cancer biomarkers may influence extended endocrine therapy (EET) treatment decisions, according to an impact study.
April 2, 2024
MIT team develops genome-editing approach for cancer mutation screening
By
Matt Limb
Scientists say they have developed a method to screen cancer-associated genetic mutations more easily and quickly than any existing approach.
March 22, 2024
Weill Cornell study may support new prognostic test for prostate tumor spread
By
LabPulse.com staff writers
Scientists working in the department of pathology and laboratory medicine at Weill Cornell Medicine have found that certain noncancerous cells may be useful for assessing prostate tumors and their potential to spread.
January 16, 2024
Polygenic risk score tests don’t meet expectations, U.K. study shows
By
Matt Limb
Polygenic risk scores “perform poorly in screening and prediction of common disease,” failing to identify nearly 90% of patients who develop disease, according to a U.K. study.
October 26, 2023
Polygenic risk scores from multi-ancestry GWASs more accurate in diverse groups: Study
By
LabPulse.com staff writers
Polygenic risk scores (PRS) derived from multi-ancestry genome-wide association studies (GWASs) outperform PRSs based on single-ancestry GWASs in underrepresented populations, new research shows.
September 21, 2023
Castle Biosciences Pittsburgh lab receives N.Y. state permit
By
LabPulse.com staff writers
Castle Biosciences has received a clinical laboratory permit from the New York State Department of Health for its Pittsburgh laboratory.
September 13, 2023
Gene expression test may improve diagnosis of febrile childhood diseases
By
Matt Limb
A simple blood test based on patterns of gene expression could radically improve and speed up the diagnosis of febrile childhood diseases, say researchers.
August 30, 2023
Gene-specific approach recommended for variant pathogenicity prediction
By
Matt Limb
A research team investigated the efficacy of gene-specific supervised machine learning in predicting the pathogenicity of rare BRCA1/2 missense variants compared to the disease-specific approach.
August 22, 2023
CareDx lands Medicare coverage for heart transplant surveillance testing
By
Nick Paul Taylor
The testing service, branded HeartCare, features AlloMap Heart and AlloSure Heart, both of which have individual Medicare coverage.
August 9, 2023
CareDx reports 13% second-quarter revenue decrease from previous year
By
LabPulse.com staff writers
The company expects full-year 2023 revenues to be in the range of $240 million to $260 million.
August 9, 2023
Viome launches at-home oral disease test
By
LabPulse.com staff writers
Viome uses the test results to provide consumers with customized food and supplement recommendations that support an individual’s oral and overall health, according to the company.
August 7, 2023
Quest Diagnostics launches consumer-initiated genetic test kit
By
LabPulse.com staff writers
The test uses next-generation sequencing (NGS) technology to analyze thousands of DNA variants in the genes associated with the conditions within the test’s scope, searching more regions in the individual’s genome than microarray testing.
July 12, 2023
Page 1 of 4
Next Page